Results 111 to 120 of about 1,092 (147)

Stimuli-Responsive Nasal in situ Gel Drug Delivery Systems: from Material Design to Clinical Translation. [PDF]

Int J Nanomedicine
He J, Wei J, Chen J, Liu T, Long H, Wei W.   +5 more
europepmc   +1 more source

The Finite Absorption Time Concept Guiding Model Informed Drug & Generics Development in Clinical Pharmacology. [PDF]

Pharm Res
Macheras P, Tsekouras AA, Sánchez-Herrero S, Kosmidis K.   +3 more
europepmc   +1 more source

Preparation, and ex vivo and in vivo Characterization of Favipiravir-Loaded Aspasomes and Niosomes for Nose-to-Brain Administration. [PDF]

Int J Nanomedicine
Salamah M, Volk B, Lekli I, Bak I, Gyöngyösi A, Kozma G, Kónya Z, Szalenkó-Tőkés Á, Kiricsi Á, Rovó L, Balogh-Weiser D, Zupkó I, Csóka I, Katona G, Balogh GT.   +14 more
europepmc   +1 more source

High-Throughput Physiologically Based Pharmacokinetic Model for Rodent Pharmacokinetics Prediction Using Machine Learning-Predicted Inputs and a Large <i>In Vivo</i> Pharmacokinetics Data Set. [PDF]

Mol Pharm
Bassani D, Andrews-Morger A, Zhang J, Docci L, Cecere G, Pähler A, Belubbi T, Laye P, Shih I, Parrott NJ.   +9 more
europepmc   +1 more source

Utility of an <i>in vitro</i> lymphatics on-chip model for rank ordering subcutaneous absorption of monoclonal antibodies. [PDF]

Lab Chip
Ledo AM, Misiewicz G, Dimke T, Tschantz WR, Handel J, Pelis R, Bruin G, Bechtold-Peters K, Sanchez-Felix M, Deshmukh S, Kim S, Proestaki M, Kamm RD.   +12 more
europepmc   +1 more source

Discovery of MK-5661, a Once-Daily Oral Na_V1.8 Inhibitor for the Treatment of Pain. [PDF]

ACS Med Chem Lett
Bungard CJ, Breslin MJ, Boyce CW, Chobanian HR, Clements MK, Dalby SM, Ehrhart J, Huang C, Jones KG, Kraus RL, Layton ME, Li Y, Madeira M, Perkins JJ, Stachel SJ, Vardigan JD, Wang D, Zhou X, Santarelli VP, Burgey CS.   +19 more
europepmc   +1 more source

Exploring the Challenges of Lipid Nanoparticle Development: The In Vitro-In Vivo Correlation Gap. [PDF]

Vaccines (Basel)
Lindsay S, Hussain M, Binici B, Perrie Y.   +3 more
europepmc   +1 more source

Enhancing pharmacokinetic properties of Chikusetsusaponin IVa via modification of polyethylenimine/poly(lactic-co-glycolic acid) nanoparticles for sustained drug delivery. [PDF]

Sci Rep
Zheng X, Li B, Deng Q, Cao G.
europepmc   +1 more source

Comparison of In Vitro and <i>In Vivo</i> Dissolution of Norvir^® Oral Powder: <i>In Vivo</i> Relevance of a too Rapid <i>In Vitro</i> Dissolution Test. [PDF]

Turk J Pharm Sci
Oktay AN, Polli JE.
europepmc   +1 more source